Ken Griffin Calyxt, Inc. Transaction History

Citadel Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.13 - $0.2 $21,248 - $32,690	163,453 New	163,453 $24,000
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.91 $2,981 - $11,303	-12,421 Reduced 48.96%	12,948 $3,000
Q1 2021 May 17, 2021	BUY	$4.25 - $12.01 $107,818 - $304,681	25,369 New	25,369 $153,000
Q2 2020 Aug 14, 2020	SELL	$2.9 - $6.36 $66,642 - $146,152	-22,980 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.48 - $7.85 $71,017 - $224,792	-28,636 Reduced 55.48%	22,980 $77,000
Q4 2019 Feb 14, 2020	BUY	$3.6 - $7.27 $138,121 - $278,928	38,367 Added 289.58%	51,616 $362,000
Q3 2019 Nov 14, 2019	SELL	$5.64 - $12.82 $17,777 - $40,408	-3,152 Reduced 19.22%	13,249 $74,000
Q2 2019 Aug 14, 2019	SELL	$12.24 - $17.4 $3,892 - $5,533	-318 Reduced 1.9%	16,401 $204,000
Q1 2019 May 15, 2019	BUY	$10.38 - $18.97 $10,826 - $19,785	1,043 Added 6.65%	16,719 $0
Q4 2018 Feb 14, 2019	SELL	$9.33 - $14.99 $24,593 - $39,513	-2,636 Reduced 14.39%	15,676 $162,000
Q2 2018 Aug 10, 2018	BUY	$13.37 - $21.46 $244,831 - $392,975	18,312 New	18,312 $0

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.